22 May 2013
Keywords: new, data, dispute, extreme, lipid-lowering, favored, many
Article | 06 September 2000
Extreme lipid-lowering, favored by many companies in their bid todevelop more effective drugs and claim a stake in this lucrative ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 September 2000
11 September 2000
21 May 2013
© 2013 thepharmaletter.com